Seizures and Renal Failures

De Deyn P.P. , Macdonald R.L. . Guanidino compounds that are increased in cerebrospinal fluid and brain or uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann Neurol 1990; 28: 626–33.

Adams H.P. , Dawson G. , Coffman T.J. , and Corry R.J. . Stroke in renal transplant recipients. Arch Neurol 1986; 43: 113–5.

Manian F.A. , Stone W.J. , Alford R.H. . Adverse antibiotic effects associated with renal insufficiency. Rev Infect Dis 1990; 12: 236–49.

Haerer A.F. . Renal failure and its treatment. Seminars in Neurology 1985; 5: 298–303.

Alrey A.C. , Micheli J.M. , Burks J. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Amer Soc Artif Intern Organs 1972; 18: 257–60.

Lederman R.J. , Henry C.E. . Progressive dialysis encephalopathy. Ann Neurol 1978; 4: 199–204.

Chui H.C. , and Damasio A.R. . Progressive dialysis encephalopathy (dialysis dementia). J Neurol 1980; 222: 145.

Sweeney V.P. , Perry T.L. , Price J.D.E. , Reeve C.E. , Godolphin W.J. , Kish S.J. . Brain gamma-aminobutyric acid deficiency in dialysis encphalopathy. Neurology 1985; 35: 180–4.

Meldrum B. . Amino acid neurotransmitters and new approaches to anticonvulsant drug action. Epilepsia 1984; 25(Suppl 2): S140–49.

Nadel A.M. , Wilson W.P. . Dialysis encephalopathy: a possible seizure disorder. Neurology 1976; 26: 1130–4.

McCauley J. , Sorkin Ml . Exacerbation of aluminium encephalopathy after treatment with desferroxamine. Nephrol Dial Transplant 1989; 4: 110–4.

Kirschbaum B.B. , Schoolwerth A.C. . Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids. Amer J Med Sci 1989; 197: 9–11.

Tyler J.R. . Neurologic disorders in renal failure. Amer J Med 1968; 44: 734–48.

McEnery P.T. , Nathan J. , Bates S.R. , Daniels S.R. . Convulsions in children undergoing renal transplantation. J Pediatr 1989; 115: 532–6.

Beaman M. , Parvin S. , Veitch P.S. , Walls J. . Convulsions associated with cyclosporin A in renal transplant recipients. Brit Med J 1985; 290: 139–40.

de Groen P. , Aksamit A.J. , Rakela J. , Forbes G.S. , Krom R.A.F. . Central nervous system toxicity after liver transplantation. New Engl J Med 1987; 317: 861–6.

Thompson C.B. , June C.H. , Sullivan K.M. , Thomas E.D. . Hypomagnesaemia and cyclosporin toxicity. Lancet 1984; 2: 1116–20.

Eschback J.W. , Abdulhadi M.H. , Browne J.K. Recombinant human erythropoietin in anemic patients with end-stage renal disease: results of a phase III multicenter clinical trial. Ann Intern Med 1989; 12: 992–1000.

Reindenberg M.M. , Drayer D.E. . Effects of renal disease upon drug disposition. Drug Metabol Rev 1978; 8: 293–302.

Levy G. . Clinical implications of interindividual differences in plasma protein binding of drugs and endogeneous substances. In: Benet L.Z. , ed. The effect of disease states on drug pharmacokinetics. Washington: Amer Pharmaceutical Assoc, 1976.

Fowler G.W. . Effect of dipropylacetate on serum levels of anticonvulsants in children. Proc West Pharmacol Soc 1978; 21: 37–40.

Soto Alvarez J. , Del Castillo J.A. , Alsar Ortiz M.J. . Effect of carbamazepine on cyclosporin blood level. Nephron 1991; 58: 235–6.

Keown P.A. , Laupacis A. , Carruthers G. Interaction between phenytoin and cyclosporin following organ transplantation. Transplantation 1984; 38: 304.